TreeWAS – Variant ID: rs11848070

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K55.0 Acute vascular disorders of intestine	0.000	0.969	0.031
J93.1 Other spontaneous pneumothorax	0.000	0.982	0.018
K55 Vascular disorders of intestine	0.000	0.982	0.018
J93 Pneumothorax	0.000	0.983	0.017
J93.9 Pneumothorax, unspecified	0.000	0.984	0.016
J93.0 Spontaneous tension pneumothorax	0.000	0.984	0.016
K55.9 Vascular disorder of intestine, unspecified	0.000	0.985	0.015
I67.8 Other specified cerebrovascular diseases	0.015	0.985	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.015	0.985	0.000
K55.2 Angiodysplasia of colon	0.000	0.987	0.013
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.013	0.987	0.000
K55.1 Chronic vascular disorders of intestine	0.000	0.987	0.013
D37.5 Rectum	0.013	0.987	0.000
D37.4 Colon	0.012	0.988	0.000
H44.2 Degenerative myopia	0.012	0.988	0.000
J93.8 Other pneumothorax	0.000	0.988	0.012
D37.1 Stomach	0.011	0.989	0.000
H44 Disorders of globe	0.011	0.989	0.000
H44.0 Purulent endophthalmitis	0.011	0.989	0.000
K55.8 Other vascular disorders of intestine	0.000	0.989	0.011
D37.6 Liver, gallbladder and bile ducts	0.011	0.989	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.010	0.990	0.000
D37.7 Other digestive organs	0.010	0.990	0.000
D37.0 Lip, oral cavity and pharynx	0.010	0.990	0.000
H44.5 Degenerated conditions of globe	0.010	0.990	0.000
D37.3 Appendix	0.010	0.990	0.000
H44.9 Disorder of globe, unspecified	0.010	0.990	0.000
D37.2 Small intestine	0.010	0.990	0.000
D37.9 Digestive organ, unspecified	0.009	0.990	0.000
H44.1 Other endophthalmitis	0.009	0.990	0.000
D38.1 Trachea, bronchus and lung	0.009	0.991	0.000
K43.0 Ventral hernia with obstruction, without gangrene	0.000	0.991	0.009
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.009	0.991	0.000
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.009	0.991	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.008	0.992	0.000
H44.6 Retained (old) intraocular foreign body, magnetic	0.008	0.992	0.000
H44.3 Other degenerative disorders of globe	0.008	0.992	0.000
H44.7 Retained (old) intraocular foreign body, nonmagnetic	0.008	0.992	0.000
D47.4 Osteomyelofibrosis	0.008	0.992	0.000
D47.3 Essential (haemorrhagic) thrombocythaemia	0.008	0.992	0.000
H44.8 Other disorders of globe	0.008	0.992	0.000
D47.1 Chronic myeloproliferative disease	0.008	0.992	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.008	0.992	0.000
D37-D48 Neoplasms of uncertain or unknown behaviour	0.008	0.992	0.000
F06.7 Mild cognitive disorder	0.008	0.992	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.007	0.992	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.007	0.992	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.007	0.992	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.007	0.992	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.007	0.992	0.000
T44.0 Anticholinesterase agents	0.007	0.992	0.000
I67.2 Cerebral atherosclerosis	0.008	0.992	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.007	0.993	0.000
D38.5 Other respiratory organs	0.007	0.993	0.000
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour	0.007	0.993	0.000
H44.4 Hypotony of eye	0.007	0.993	0.000
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.007	0.993	0.000
D38.2 Pleura	0.007	0.993	0.000
D38.0 Larynx	0.007	0.993	0.000
D38.3 Mediastinum	0.007	0.993	0.000
I67 Other cerebrovascular diseases	0.007	0.993	0.000
D38.6 Respiratory organ, unspecified	0.006	0.993	0.000
D38.4 Thymus	0.006	0.993	0.000
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]	0.006	0.993	0.000
L29.9 Pruritus, unspecified	0.000	0.994	0.006
C18.7 Sigmoid colon	0.000	0.994	0.006
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.006	0.994	0.000
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified	0.006	0.994	0.000
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system	0.006	0.994	0.000
D46 Myelodysplastic syndromes	0.006	0.994	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.006	0.994	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.006	0.994	0.000
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.006	0.994	0.000
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.005	0.995	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.005	0.995	0.000
M25.86 Other specified joint disorders (Lower leg)	0.005	0.995	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.005	0.995	0.000
I67.5 Moyamoya disease	0.005	0.995	0.000
I67.4 Hypertensive encephalopathy	0.005	0.995	0.000
I67.3 Progressive vascular leukoencephalopathy	0.005	0.995	0.000
I67.6 Nonpyogenic thrombosis of intracranial venous system	0.005	0.995	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.005	0.995	0.000
T36 Poisoning by systemic antibiotics	0.005	0.995	0.000
I67.0 Dissection of cerebral arteries, nonruptured	0.005	0.995	0.000
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.005	0.995	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.005	0.995	0.000
D46.2 Refractory anaemia with excess of blasts	0.005	0.995	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.005	0.995	0.000
D46.7 Other myelodysplastic syndromes	0.005	0.995	0.000
D44.0 Thyroid gland	0.005	0.995	0.000
D43.1 Brain, infratentorial	0.005	0.995	0.000
D43.0 Brain, supratentorial	0.005	0.995	0.000
D39.7 Other female genital organs	0.005	0.995	0.000
N36.0 Urethral fistula	0.000	0.995	0.005
D42.9 Meninges, unspecified	0.004	0.995	0.000
T36.0 Penicillins	0.005	0.995	0.000
T46.1 Calcium-channel blockers	0.004	0.995	0.000
D42.1 Spinal meninges	0.004	0.995	0.000
D42.0 Cerebral meninges	0.004	0.995	0.000
D39.0 Uterus	0.004	0.996	0.000
D43.9 Central nervous system, unspecified	0.004	0.996	0.000
D43.7 Other parts of central nervous system	0.004	0.996	0.000
D43.3 Cranial nerves	0.004	0.996	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.004	0.996	0.000
I67.7 Cerebral arteritis, not elsewhere classified	0.004	0.996	0.000
D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality	0.004	0.996	0.000
D46.3 Refractory anaemia with excess of blasts with transformation	0.004	0.996	0.000
D46.9 Myelodysplastic syndrome, unspecified	0.004	0.996	0.000
D46.0 Refractory anaemia without sideroblasts, so stated	0.004	0.996	0.000
D40.0 Prostate	0.004	0.996	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.004	0.996	0.000
T46.7 Peripheral vasodilators	0.004	0.996	0.000
D43.4 Spinal cord	0.004	0.996	0.000
D46.1 Refractory anaemia with sideroblasts	0.004	0.996	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.004	0.996	0.000
D39.9 Female genital organ, unspecified	0.004	0.996	0.000
D39.2 Placenta	0.004	0.996	0.000
T36.8 Other systemic antibiotics	0.004	0.996	0.000
I67.1 Cerebral aneurysm, nonruptured	0.004	0.996	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.004	0.996	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.004	0.996	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.004	0.996	0.000
T38.0 Glucocorticoids and synthetic analogues	0.004	0.996	0.000
K43 Ventral hernia	0.000	0.996	0.004
D40.9 Male genital organ, unspecified	0.004	0.996	0.000
D46.5 Refractory anaemia with multi-lineage dysplasia	0.004	0.996	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.004	0.996	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.004	0.996	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.004	0.996	0.000
D43.2 Brain, unspecified	0.004	0.996	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.004	0.996	0.000
T38.1 Thyroid hormones and substitutes	0.004	0.996	0.000
C18.2 Ascending colon	0.000	0.996	0.004
T47.0 Histamine H(2)-receptor antagonists	0.004	0.996	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.004	0.996	0.000
D40.7 Other male genital organs	0.004	0.996	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.004	0.996	0.000
T38.5 Other oestrogens and progestogens	0.004	0.996	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.004	0.996	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.004	0.996	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.004	0.996	0.000
D44.7 Aortic body and other paraganglia	0.004	0.996	0.000
D46.4 Refractory anaemia, unspecified	0.004	0.996	0.000
T38.9 Other and unspecified hormone antagonists	0.004	0.996	0.000
T38.7 Androgens and anabolic congeners	0.004	0.996	0.000
T38.4 Oral contraceptives	0.004	0.996	0.000
T38.2 Antithyroid drugs	0.004	0.996	0.000
T47.2 Stimulant laxatives	0.004	0.996	0.000
D44.4 Craniopharyngeal duct	0.004	0.996	0.000
T36.9 Systemic antibiotic, unspecified	0.004	0.996	0.000
T36.7 Antifungal antibiotics, systemically used	0.004	0.996	0.000
T36.6 Rifamycins	0.004	0.996	0.000
T36.5 Aminoglycosides	0.004	0.996	0.000
T36.2 Chloramphenicol group	0.004	0.996	0.000
N36.2 Urethral caruncle	0.000	0.996	0.004
N36 Other disorders of urethra	0.000	0.996	0.004
D44.5 Pineal gland	0.003	0.996	0.000
D44.2 Parathyroid gland	0.003	0.996	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.004	0.996	0.000
N36.3 Prolapsed urethral mucosa	0.000	0.996	0.004
T36.4 Tetracyclines	0.004	0.996	0.000
C18 Malignant neoplasm of colon	0.000	0.996	0.004
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.004	0.996	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.004	0.996	0.000
T47.7 Emetics	0.004	0.996	0.000
T47.5 Digestants	0.004	0.996	0.000
T47.3 Saline and osmotic laxatives	0.004	0.996	0.000
T80.8 Other complications following infusion, transfusion and therapeutic injection	0.000	0.996	0.004
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.003	0.996	0.000
C18.1 Appendix	0.000	0.996	0.004
K56.4 Other impaction of intestine	0.000	0.996	0.004
D44.9 Endocrine gland, unspecified	0.003	0.996	0.000
K43.1 Ventral hernia with gangrene	0.000	0.996	0.003
T48.6 Antiasthmatics, not elsewhere classified	0.003	0.996	0.000
T47.4 Other laxatives	0.003	0.996	0.000
T36.3 Macrolides	0.003	0.996	0.000
D40.1 Testis	0.003	0.997	0.000
T45.0 Antiallergic and antiemetic drugs	0.003	0.997	0.000
D44.8 Pluriglandular involvement	0.003	0.997	0.000
H59.8 Other postprocedural disorders of eye and adnexa	0.000	0.997	0.003
T47.6 Antidiarrhoeal drugs	0.003	0.997	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.003	0.997	0.000
T37.5 Antiviral drugs	0.003	0.997	0.000
T37.4 Anthelminthics	0.003	0.997	0.000
T37.3 Other antiprotozoal drugs	0.003	0.997	0.000
T37.1 Antimycobacterial drugs	0.003	0.997	0.000
T37.0 Sulphonamides	0.003	0.997	0.000
T50.4 Drugs affecting uric acid metabolism	0.003	0.997	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.003	0.997	0.000
N86 Erosion and ectropion of cervix uteri	0.000	0.997	0.003
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.003	0.997	0.000
T48.4 Expectorants	0.003	0.997	0.000
T48.3 Antitussives	0.003	0.997	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.003	0.997	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.003	0.997	0.000
T48.0 Oxytocic drugs	0.003	0.997	0.000
D44.6 Carotid body	0.003	0.997	0.000
K43.7 Other and unspecified ventral hernia with gangrene	0.000	0.997	0.003
K43.6 Other and unspecified ventral hernia with obstruction, without gangrene	0.000	0.997	0.003
K43.5 Parastomal hernia without obstruction or gangrene	0.000	0.997	0.003
K43.4 Parastomal hernia with gangrene	0.000	0.997	0.003
K43.3 Parastomal hernia with obstruction, without gangrene	0.000	0.997	0.003
K43.2 Incisional hernia without obstruction or gangrene	0.000	0.997	0.003
F06 Other mental disorders due to brain damage and dysfunction and to physical disease	0.003	0.997	0.000
M23.51 Chronic instability of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.003	0.997	0.000
T48.5 Anti-common-cold drugs	0.003	0.997	0.000
T45.2 Vitamins, not elsewhere classified	0.003	0.997	0.000
T50.7 Analeptics and opioid receptor antagonists	0.003	0.997	0.000
T50.5 Appetite depressants	0.003	0.997	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.003	0.997	0.000
T50.0 Mineralocorticoids and their antagonists	0.003	0.997	0.000
N36.8 Other specified disorders of urethra	0.000	0.997	0.003
T41.5 Therapeutic gases	0.003	0.997	0.000
T41.4 Anaesthetic, unspecified	0.003	0.997	0.000
T41.3 Local anaesthetics	0.003	0.997	0.000
T41.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
T41.1 Intravenous anaesthetics	0.003	0.997	0.000
T41.0 Inhaled anaesthetics	0.003	0.997	0.000
T50.8 Diagnostic agents	0.003	0.997	0.000
L29.0 Pruritus ani	0.000	0.997	0.003
T37.2 Antimalarials and drugs acting on other blood protozoa	0.003	0.997	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.003	0.997	0.000
T45.8 Other primarily systemic and haematological agents	0.003	0.997	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.997	0.000
T45.6 Fibrinolysis-affecting drugs	0.003	0.997	0.000
T45.4 Iron and its compounds	0.003	0.997	0.000
T45.3 Enzymes, not elsewhere classified	0.003	0.997	0.000
D45 Polycythaemia vera	0.003	0.997	0.000
D39.1 Ovary	0.003	0.997	0.000
H11.3 Conjunctival haemorrhage	0.003	0.997	0.000
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.003	0.997	0.000
L29 Pruritus	0.000	0.997	0.003
T50.6 Antidotes and chelating agents, not elsewhere classified	0.003	0.997	0.000
T49.9 Topical agent, unspecified	0.003	0.997	0.000
T49.8 Other topical agents	0.003	0.997	0.000
T49.7 Dental drugs, topically applied	0.003	0.997	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.003	0.997	0.000
T49.5 Ophthalmological drugs and preparations	0.003	0.997	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.997	0.000
T49.3 Emollients, demulcents and protectants	0.003	0.997	0.000
T49.2 Local astringents and local detergents	0.003	0.997	0.000
T49.1 Antipruritics	0.003	0.997	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
T50.1 Loop [high-ceiling] diuretics	0.003	0.997	0.000
Z29.8 Other specified prophylactic measures	0.000	0.997	0.003
T45.5 Anticoagulants	0.003	0.997	0.000
C18.9 Colon, unspecified	0.000	0.997	0.003
C18.3 Hepatic flexure	0.000	0.997	0.003
D44.1 Adrenal gland	0.002	0.997	0.001
D47.2 Monoclonal gammopathy	0.001	0.997	0.001
D13.0 Oesophagus	0.000	0.997	0.003
D44.3 Pituitary gland	0.002	0.997	0.000
K43.9 Ventral hernia without obstruction or gangrene	0.000	0.997	0.003
N36.1 Urethral diverticulum	0.000	0.997	0.003
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.997	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.003	0.997	0.000
C18.4 Transverse colon	0.000	0.997	0.003
F06.2 Organic delusional [schizophrenia-like] disorder	0.003	0.997	0.000
C18.6 Descending colon	0.000	0.997	0.003
M65.34 Trigger finger-Hand	0.003	0.997	0.000
C18.8 Overlapping lesion of colon	0.000	0.997	0.002
N36.9 Urethral disorder, unspecified	0.000	0.997	0.003
F06.6 Organic emotionally labile [asthenic] disorder	0.002	0.997	0.000
F06.5 Organic dissociative disorder	0.002	0.997	0.000
F06.4 Organic anxiety disorder	0.002	0.997	0.000
F06.1 Organic catatonic disorder	0.002	0.997	0.000
F06.0 Organic hallucinosis	0.002	0.997	0.000
C44.1 Skin of eyelid, including canthus	0.003	0.997	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.003	0.997	0.000
I08.1 Disorders of both mitral and tricuspid valves	0.003	0.997	0.000
F06.8 Other specified mental disorders due to brain damage and dysfunction and to physical disease	0.002	0.997	0.000
F06.3 Organic mood [affective] disorders	0.002	0.997	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.002	0.997	0.000
D48.2 Peripheral nerves and autonomic nervous system	0.002	0.997	0.000
H11.1 Conjunctival degenerations and deposits	0.002	0.998	0.000
D48.3 Retroperitoneum	0.002	0.998	0.000
L29.1 Pruritus scroti	0.000	0.998	0.002
D48.7 Other specified sites	0.002	0.998	0.000
J94.2 Haemothorax	0.000	0.998	0.002
J94 Other pleural conditions	0.000	0.998	0.002
K59.1 Functional diarrhoea	0.000	0.998	0.002
J90-J94 Other diseases of pleura	0.000	0.998	0.002
D48.0 Bone and articular cartilage	0.002	0.998	0.000
L29.8 Other pruritus	0.000	0.998	0.002
T42.1 Iminostilbenes	0.002	0.998	0.000
B91 Sequelae of poliomyelitis	0.000	0.998	0.002
E28.2 Polycystic ovarian syndrome	0.002	0.998	0.000
Z01.5 Diagnostic skin and sensitisation tests	0.000	0.998	0.002
H43-H45 Disorders of vitreous body and globe	0.002	0.998	0.000
C22.9 Liver, unspecified	0.002	0.998	0.000
D48.9 Neoplasms of uncertain or unknown behaviour, unspecified	0.002	0.998	0.000
D48.4 Peritoneum	0.002	0.998	0.000
F06.9 Unspecified mental disorder due to brain damage and dysfunction and to physical disease	0.002	0.998	0.000
L29.3 Anogenital pruritus, unspecified	0.000	0.998	0.002
S52.70 Multiple fractures of forearm (closed)	0.002	0.998	0.000
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.002	0.998	0.000
C18.5 Splenic flexure	0.000	0.998	0.002
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.002	0.998	0.000
N27.0 Small kidney, unilateral	0.000	0.998	0.002
S02.20 Fracture of nasal bones (closed)	0.002	0.998	0.000
C62.9 Testis, unspecified	0.000	0.998	0.002
J94.8 Other specified pleural conditions	0.000	0.998	0.002
D48.5 Skin	0.002	0.998	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.002	0.998	0.000
T42.2 Succinimides and oxazolidinediones	0.002	0.998	0.000
C18.0 Caecum	0.000	0.998	0.002
K59.8 Other specified functional intestinal disorders	0.000	0.998	0.002
M65.43 Radial styloid tenosynovitis [de Quervain] (Forearm)	0.000	0.998	0.002
T42.3 Barbiturates	0.002	0.998	0.000
D48.6 Breast	0.002	0.998	0.000
O41.0 Oligohydramnios	0.002	0.998	0.000
M25.81 Other specified joint disorders (Shoulder region)	0.002	0.998	0.000
J94.0 Chylous effusion	0.000	0.998	0.002
E14.9 Without complications	0.000	0.998	0.002
I11.9 Hypertensive heart disease without (congestive) heart failure	0.000	0.998	0.002
J92 Pleural plaque	0.000	0.998	0.002
J94.9 Pleural condition, unspecified	0.000	0.998	0.002
H11 Other disorders of conjunctiva	0.002	0.998	0.000
H45 Disorders of vitreous body and globe in diseases classified elsewhere	0.002	0.998	0.000
L90.0 Lichen sclerosus et atrophicus	0.000	0.998	0.002
O42.0 Premature rupture of membranes, onset of labour within 24 hours	0.002	0.998	0.000
T42.0 Hydantoin derivatives	0.002	0.998	0.000
C22.0 Liver cell carcinoma	0.002	0.998	0.000
J94.1 Fibrothorax	0.000	0.998	0.002
L60.8 Other nail disorders	0.000	0.998	0.002
D41.9 Urinary organ, unspecified	0.002	0.998	0.000
D41.7 Other urinary organs	0.002	0.998	0.000
D41.3 Urethra	0.002	0.998	0.000
E28.3 Primary ovarian failure	0.002	0.998	0.000
E14.1 With ketoacidosis	0.000	0.998	0.002
J92.9 Pleural plaque without asbestos	0.000	0.998	0.002
K58.0 Irritable bowel syndrome with diarrhoea	0.000	0.998	0.002
T80.1 Vascular complications following infusion, transfusion and therapeutic injection	0.000	0.998	0.002
T80 Complications following infusion, transfusion and therapeutic injection	0.000	0.998	0.002
E28 Ovarian dysfunction	0.002	0.998	0.000
M21.26 Flexion deformity (Lower leg)	0.000	0.998	0.002
I71.0 Dissection of aorta [any part]	0.000	0.998	0.002
D41.1 Renal pelvis	0.002	0.998	0.000
C62.1 Descended testis	0.000	0.998	0.002
D41.2 Ureter	0.001	0.998	0.000
H45.0 Vitreous haemorrhage in diseases classified elsewhere	0.001	0.998	0.000
M25.8 Other specified joint disorders	0.002	0.998	0.000
N76.2 Acute vulvitis	0.002	0.998	0.000
H45.8 Other disorders of vitreous body and globe in diseases classified elsewhere	0.001	0.998	0.000
H45.1 Endophthalmitis in diseases classified elsewhere	0.001	0.998	0.000
K42.0 Umbilical hernia with obstruction, without gangrene	0.000	0.998	0.002
E14 Unspecified diabetes mellitus	0.000	0.998	0.002
M25.83 Other specified joint disorders (Forearm)	0.002	0.998	0.000
E14.4 With neurological complications	0.000	0.998	0.002
H11.9 Disorder of conjunctiva, unspecified	0.002	0.998	0.000
L29.2 Pruritus vulvae	0.000	0.998	0.001
T80.9 Unspecified complication following infusion, transfusion and therapeutic injection	0.000	0.998	0.002
I10 Essential (primary) hypertension	0.000	0.998	0.002
H11.0 Pterygium	0.002	0.998	0.000
O80.0 Spontaneous vertex delivery	0.002	0.998	0.000
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.002	0.998	0.000
M21.07 Valgus deformity, not elsewhere classified (Ankle and foot)	0.000	0.998	0.002
E14.6 With other specified complications	0.000	0.998	0.001
T80.6 Other serum reactions	0.000	0.998	0.001
T80.5 Anaphylactic shock due to serum	0.000	0.998	0.001
T80.4 Rh incompatibility reaction	0.000	0.998	0.001
T80.3 ABO incompatibility reaction	0.000	0.998	0.001
T80.0 Air embolism following infusion, transfusion and therapeutic injection	0.000	0.998	0.001
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified	0.000	0.998	0.002
K59 Other functional intestinal disorders	0.000	0.998	0.002
E28.9 Ovarian dysfunction, unspecified	0.001	0.998	0.000
E28.8 Other ovarian dysfunction	0.001	0.998	0.000
E28.1 Androgen excess	0.001	0.998	0.000
E28.0 Oestrogen excess	0.001	0.998	0.000
X51.9 Unspecified place	0.000	0.998	0.002
E14.8 With unspecified complications	0.000	0.998	0.001
H11.2 Conjunctival scars	0.001	0.998	0.000
N48.2 Other inflammatory disorders of penis	0.000	0.998	0.002
C62 Malignant neoplasm of testis	0.000	0.998	0.002
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.001	0.998	0.000
N76.4 Abscess of vulva	0.002	0.998	0.000
M25.89 Other specified joint disorders (Site unspecified)	0.001	0.998	0.000
M25.80 Other specified joint disorders (Multiple sites)	0.001	0.998	0.000
C90.0 Multiple myeloma	0.000	0.998	0.001
E14.2 Withrenal complications	0.000	0.998	0.001
H35.9 Retinal disorder, unspecified	0.000	0.998	0.001
I71.4 Abdominal aortic aneurysm, without mention of rupture	0.000	0.998	0.002
S50.0 Contusion of elbow	0.000	0.999	0.001
E14.7 With multiple complications	0.000	0.999	0.001
E21.3 Hyperparathyroidism, unspecified	0.001	0.999	0.000
M25.85 Other specified joint disorders (Pelvic region and thigh)	0.001	0.999	0.000
M54.47 Lumbago with sciatica (Lumbosacral region)	0.001	0.999	0.000
D13.1 Stomach	0.000	0.999	0.001
H59.9 Postprocedural disorder of eye and adnexa, unspecified	0.000	0.999	0.001
R44.8 Other and unspecified symptoms and signs involving general sensations and perceptions	0.001	0.999	0.000
M25.88 Other specified joint disorders (Other)	0.001	0.999	0.000
N83.1 Corpus luteum cyst	0.000	0.999	0.001
R82.8 Abnormal findings on cytological and histological examination of urine	0.000	0.999	0.001
E14.0 With coma	0.000	0.999	0.001
M54.46 Lumbago with sciatica (Lumbar region)	0.001	0.999	0.000
M79.29 Neuralgia and neuritis, unspecified (Site unspecified)	0.001	0.999	0.000
D04.3 Skin of other and unspecified parts of face	0.000	0.999	0.001
E14.3 With ophthalmic complications	0.000	0.999	0.001
K56.0 Paralytic ileus	0.000	0.999	0.001
K59.2 Neurogenic bowel, not elsewhere classified	0.000	0.999	0.001
N27.1 Small kidney, bilateral	0.000	0.999	0.001
S72.20 Subtrochanteric fracture (closed)	0.000	0.999	0.001
C17.2 Ileum	0.000	0.999	0.001
G03.9 Meningitis, unspecified	0.001	0.999	0.000
I71.6 Thoracoabdominal aortic aneurysm, without mention of rupture	0.000	0.999	0.001
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.001	0.999	0.000
T40.8 Lysergide [LSD]	0.001	0.999	0.000
T40.7 Cannabis (derivatives)	0.001	0.999	0.000
T40.5 Cocaine	0.001	0.999	0.000
T40.3 Methadone	0.001	0.999	0.000
T40.0 Opium	0.001	0.999	0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.001	0.999	0.000
C62.0 Undescended testis	0.000	0.999	0.001
I07.1 Tricuspid insufficiency	0.001	0.999	0.000
K91.3 Postoperative intestinal obstruction	0.000	0.999	0.001
I71 Aortic aneurysm and dissection	0.000	0.999	0.001
M06.09 Seronegative rheumatoid arthritis (Site unspecified)	0.000	0.999	0.001
M25.82 Other specified joint disorders (Upper arm)	0.001	0.999	0.000
E14.5 With peripheral circulatory complications	0.000	0.999	0.001
H11.4 Other conjunctival vascular disorders and cysts	0.001	0.999	0.000
I71.9 Aortic aneurysm of unspecified site, without mention of rupture	0.000	0.999	0.001
N27 Small kidney of unknown cause	0.000	0.999	0.001
E73.9 Lactose intolerance, unspecified	0.000	0.999	0.001
J92.0 Pleural plaque with presence of asbestos	0.000	0.999	0.001
M65.3 Trigger finger	0.001	0.999	0.000
M43.09 Spondylolysis (Site unspecified)	0.001	0.999	0.000
S72.90 Fracture of femur, part unspecified (closed)	0.000	0.999	0.001
D41.0 Kidney	0.001	0.999	0.000
E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified	0.000	0.999	0.001
H11.8 Other specified disorders of conjunctiva	0.001	0.999	0.000
J15.1 Pneumonia due to Pseudomonas	0.001	0.999	0.000
T40.1 Heroin	0.001	0.999	0.000
S02.2 Fracture of nasal bones	0.001	0.999	0.000
M62.81 Other specified disorders of muscle (Shoulder region)	0.000	0.999	0.001
H59.0 Vitreous syndrome following cataract surgery	0.000	0.999	0.001
H65.3 Chronic mucoid otitis media	0.000	0.999	0.001
K59.9 Functional intestinal disorder, unspecified	0.000	0.999	0.001
N84.3 Polyp of vulva	0.000	0.999	0.001
S02.21 Fracture of nasal bones (open)	0.001	0.999	0.000
N27.9 Small kidney, unspecified	0.000	0.999	0.001
M43.02 Spondylolysis (Cervical region)	0.001	0.999	0.000
C22.7 Other specified carcinomas of liver	0.001	0.999	0.000
C22.4 Other sarcomas of liver	0.001	0.999	0.000
C22.3 Angiosarcoma of liver	0.001	0.999	0.000
C22.2 Hepatoblastoma	0.001	0.999	0.000
I71.8 Aortic aneurysm of unspecified site, ruptured	0.000	0.999	0.001
I71.5 Thoracoabdominal aortic aneurysm, ruptured	0.000	0.999	0.001
I71.1 Thoracic aortic aneurysm, ruptured	0.000	0.999	0.001
R09.0 Asphyxia	0.001	0.999	0.000
T40.4 Other synthetic narcotics	0.000	0.999	0.001
M65.39 Trigger finger-Site unspec	0.001	0.999	0.000
M65.38 Trigger finger-Other	0.001	0.999	0.000
M65.37 Trigger finger-Ankle/foot	0.001	0.999	0.000
M65.36 Trigger finger-Lower leg	0.001	0.999	0.000
M65.35 Trigger finger-Pelvic/thigh	0.001	0.999	0.000
M65.33 Trigger finger-Forearm	0.001	0.999	0.000
M65.32 Trigger finger-Upper arm	0.001	0.999	0.000
M65.31 Trigger finger-Shldr region	0.001	0.999	0.000
M65.30 Trigger finger-Mult sites	0.001	0.999	0.000
A87.9 Viral meningitis, unspecified	0.000	0.999	0.001
K59.4 Anal spasm	0.000	0.999	0.001
K62.6 Ulcer of anus and rectum	0.001	0.999	0.000
T40.6 Other and unspecified narcotics	0.001	0.999	0.001
K56 Paralytic ileus and intestinal obstruction without hernia	0.000	0.999	0.001
M65.44 Radial styloid tenosynovitis [de Quervain] (Hand)	0.000	0.999	0.001
C25.2 Tail of pancreas	0.001	0.999	0.000
K56.1 Intussusception	0.000	0.999	0.001
M65.4 Radial styloid tenosynovitis [de Quervain]	0.000	0.999	0.001
S83.2 Tear of meniscus, current	0.001	0.999	0.000
Z32.0 Pregnancy, not (yet) confirmed	0.001	0.999	0.000
M62.56 Muscle wasting and atrophy, not elsewhere classified (Lower leg)	0.000	0.999	0.001
K91.9 Postprocedural disorder of digestive system, unspecified	0.000	0.999	0.001
T80.2 Infections following infusion, transfusion and therapeutic injection	0.000	0.999	0.001
M43.0 Spondylolysis	0.001	0.999	0.000
S72.2 Subtrochanteric fracture	0.000	0.999	0.001
C69.0 Conjunctiva	0.001	0.999	0.000
F01.1 Multi-infarct dementia	0.001	0.999	0.000
H66.9 Otitis media, unspecified	0.001	0.999	0.000
R44.3 Hallucinations, unspecified	0.001	0.999	0.000
S70.0 Contusion of hip	0.000	0.999	0.001
I11 Hypertensive heart disease	0.000	0.999	0.001
M43.08 Spondylolysis (Sacral and sacrococcygeal region)	0.001	0.999	0.000
I71.3 Abdominal aortic aneurysm, ruptured	0.000	0.999	0.001
R44.0 Auditory hallucinations	0.001	0.999	0.000
S72.9 Fracture of femur, part unspecified	0.000	0.999	0.001
Z56.3 Stressful work schedule	0.000	0.999	0.001
M65.49 Radial styloid tenosynovitis [de Quervain]-Site unspec	0.000	0.999	0.001
M65.48 Radial styloid tenosynovitis [de Quervain]-Other	0.000	0.999	0.001
M65.47 Radial styloid tenosynovitis [de Quervain]-Ankle/foot	0.000	0.999	0.001
M65.46 Radial styloid tenosynovitis [de Quervain]-Lower leg	0.000	0.999	0.001
M65.45 Radial styloid tenosynovitis [de Quervain]-Pelvic/thigh	0.000	0.999	0.001
M65.42 Radial styloid tenosynovitis [de Quervain]-Upper arm	0.000	0.999	0.001
M65.41 Radial styloid tenosynovitis [de Quervain]-Shldr region	0.000	0.999	0.001
M65.40 Radial styloid tenosynovitis [de Quervain] (Multiple sites)	0.000	0.999	0.001
C25.9 Pancreas, unspecified	0.001	0.999	0.000
C49.9 Connective and soft tissue, unspecified	0.000	0.999	0.001
D05.1 Intraductal carcinoma in situ	0.000	0.999	0.001
E26.0 Primary hyperaldosteronism	0.001	0.999	0.000
R82.9 Other and unspecified abnormal finding in urine	0.000	0.999	0.001
M21.27 Flexion deformity (Ankle and foot)	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations